Treatment with small-molecule Hh signaling inhibitors inhibits cell proliferation in the ERMS cell lines, which suggested that GLI1 could be an effective therapeutic target for ERMS [27]. The gene discussed is GLI1; the disease is embryonal rhabdomyosarcoma.